πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 15 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12414953

Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

Prelude Therapeutics, Incorporated Β· Granted Tue Sep 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12129262

CDK inhibitors and their use as pharmaceuticals

Prelude Therapeutics, Incorporated Β· Granted Tue Oct 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11939340

CDK inhibitors and their use as pharmaceuticals

Prelude Therapeutics, Incorporated Β· Granted Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11702423

BRM targeting compounds and associated methods of use

Prelude Therapeutics, Incorporated Β· Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11685744

CDK inhibitors and their use as pharmaceuticals

Prelude Therapeutics, Incorporated Β· Granted Tue Jun 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11673893

CDK inhibitors and their use as pharmaceuticals

Prelude Therapeutics, Incorporated Β· Granted Tue Jun 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11622970

BCL-2 inhibitors and their use as pharmaceuticals

Prelude Therapeutics, Incorporated Β· Granted Tue Apr 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11524962

Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein arginine methyl transferase

Prelude Therapeutics, Incorporated Β· Granted Tue Dec 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11254683

Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

Prelude Therapeutics, Incorporated Β· Granted Tue Feb 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11220524

Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

Prelude Therapeutics, Incorporated Β· Granted Tue Jan 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11214574

Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

Prelude Therapeutics, Incorporated Β· Granted Tue Jan 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11208416

Selective inhibitors of protein arginine methytransterase 5 (PRMT5)

Prelude Therapeutics, Incorporated Β· Granted Tue Dec 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11078205

Selective inhibitors of protein arginine methlytransferase 5 (PRMT5)

Prelude Therapeutics, Incorporated Β· Granted Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10711007

Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

Prelude Therapeutics, Incorporated Β· Granted Tue Jul 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10570140

Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

Prelude Therapeutics, Incorporated Β· Granted Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted